ShareValue scores for 688363.SHG: Valuation 36, Quality 59, Growth 29, Health 59.

688363.SHG
SSE

Bloomage Biotechnology Corp Ltd

CN¥38.76(+1.79%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

-6% to 9%
Valuation
36
Overvalued
Price vs Value
Quality
59
Moderate
Business Strength
Growth
29
Weak
Revenue & Earnings
Health
59
Moderate
Financial Stability
Momentum
34
Bearish
Price Trend

Company Details

About

Bloomage BioTechnology Corporation Limited researchers, develops, produces, and sells bioactive materials. It offers pharmaceutical grade sodium hyaluronate which can be used as an API or excipient for drugs and medical devices in ophthalmic preparations, intra-articular injections, anti-adhesive preparations, and topical preparations for wound healing and soft tissue filler under the Hyature name; and cosmetic grade sodium hyaluronate solutions for cosmetic products, including moisturizing, repairing, delay skin aging, and brightening under the Hybloom, miniHA, microHA, Hyacross, Hyacolor, and cationHA. The company also provides food-grade sodium hyaluronate for use in food/healthy food/dietary supplements under the HAPLEX name, as well as food-grade gamma aminobutyric acid under the Gabarelax name; hyaluronic acid for oral care under the Biomoist name; and animal care products under the HYAPET names. Bloomage BioTechnology Corporation Limited was founded in 2000 and is based in Jinan, China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026